CARYSIL LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 954.1 INR | -0.10% |
|
+2.11% | +16.02% |
| Mar. 20 | Carysil to Raise Up to INR1.50 Billion Via Qualified Institutional Placement | MT |
| Feb. 01 | Transcript : Carysil Limited, Q3 2024 Earnings Call, Feb 01, 2024 |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Analyst opinion has improved significantly over the past four months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- With an expected P/E ratio at 38.94 and 24.15 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Sector: Construction Supplies & Fixtures
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +16.02% | 307M | - | ||
| +12.87% | 40.33B | C+ | ||
| +3.17% | 30.34B | C+ | ||
| +12.41% | 22.89B | C | ||
| +28.21% | 19.09B | B+ | ||
| +4.28% | 15.38B | A- | ||
| +9.35% | 9.84B | B | ||
| -2.57% | 9.32B | B | ||
| +10.03% | 7.75B | B+ | ||
| -12.31% | 7.37B | A- |
Investor Rating
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- CARYSIL Stock
- Ratings Carysil Limited
